Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Question

<< Previous

Bullboard Posts

Next >>

Comment by mercedesmanon Jul 19, 2022 9:12pm

161 Views

Post# 34835985

RE:RE:RE:Question

Quacker wrote: Don't you think that Baxter has bought Spectral already at a good discount. Reason the stock is only going up a little at a time. No one in company with a position of power cares about the price. They know what it will sell for. I have owned shares since the cardiac invention. Why is Paradiam not saying anything.

Are you suggesting that Spectral and Baxter already have a signed deal wherein Baxter will purchase either Spectral as a whole or the NA Rights to PMX ?

MM

<< Previous

Bullboard Posts

Next >>

High-growth stock Happy Belly opens first Rosie's Burgers in Alberta